Sponsor:
Dana-Farber Cancer Institute
Code:
NCT04986579
Conditions
Metastatic Breast Cancer
Chemotherapy-induced Alopecia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Paxman Scalp Cooling System
Eribulin
Sacituzumab govitecan
Trastuzumab deruxtecan
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-15. This information was provided to ClinicalTrials.gov by Dana-Farber Cancer Institute on 2026-06-18.